TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Tillotts Pharma AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover | 36,320 | 41,393 | 31,678 |
Financial expenses | 412 | 18 | 178 |
Earnings before taxes | 388 | 1,040 | 522 |
EBITDA | 643 | 1,049 | 511 |
Total assets | 17,143 | 14,476 | 21,014 |
Current assets | 17,120 | 14,454 | 20,954 |
Current liabilities | 11,788 | 9,412 | 16,380 |
Equity capital | 4,093 | 3,806 | 3,265 |
- share capital | 9 | 9 | 10 |
Employees (average) | 21 | 19 | 18 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency | 23.9% | 26.3% | 15.5% |
Turnover per employee | 1,730 | 2,179 | 1,760 |
Profit as a percentage of turnover | 1.1% | 2.5% | 1.6% |
Return on assets (ROA) | 4.7% | 7.3% | 3.3% |
Current ratio | 145.2% | 153.6% | 127.9% |
Return on equity (ROE) | 9.5% | 27.3% | 16.0% |
Change turnover | -5,194 | 12,281 | 458 |
Change turnover % | -13% | 42% | 1% |
Chg. No. of employees | 2 | 1 | 2 |
Chg. No. of employees % | 11% | 6% | 13% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.